OT-101’s mechanisms of action against COVID-19 are as following: (1) reduce TGF-β production/secretion [94]; (2) inhibition of cellular binding; (3) inhibition of viral replication; and (4) suppression of viral-induced pneumonia [91,95]. This evidence concerns the gene TGFB1 and COVID-19.